Introduction
The cellular events at implantation and placentation in primate species have been studied using the macaque and the baboon (Hendrickx, 1971; Enders and Schlafke, 1986) . A study of the early stages of implantation revealed that penetration of uterine epithelium by syncytial trophoblast cells occurs on day 9.5 of gestation followed by marked proliferation of cytotrophoblast cells which form the trophoblast plate (Enders et al., 1985) . Endothelial basal lamina are penetrated by cytoplasmic processes arising from syncytial trophoblast cells, and at this time syncytial clefts and lacunae lined by polarized lamellar syncytiotrophblast cells also begin to develop (Enders and King, 1991) . By day 12 of gestation, lacunae undergo further development and become filled with maternal blood as syncytio-and cytotrophoblast cells penetrate maternal blood vessels. The responses of maternal endometrium during trophoblast penetration is characterized by marked oedema in the upper functionalis and transformation of epithelial cells at
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neck of glands to form nests of plaque acini. Stromal cell decidualization along with an influx of endometrial granulated lymphocytes then begins by day 14 of gestation as plaque acini begin to degenerate (Enders et al., 1985) .
The dynamic process of trophoblast invasion into maternal endometrium and vasculature is associated with extensive cellcell and cell-matrix interactions involving various adhesion molecules and matrix metalloproteinases (Librach et al., 1991; Blankenship et al., 1993a,b; Enders and Blankenship, 1997) . However, the cellular mediators which can affect the process of blastocyst implantation during the early stages of gestation remain largely unknown. Immunohistochemical analyses of receptors for oestradiol-17β (ER) and progesterone (PR) at fetal-maternal interface in timed pre-villous and villous stages of implantation of Rhesus monkey revealed the presence of PR in syncytio-and cytotrophoblast cells, while these cells were generally ER negative. These analyses also showed that maternal endometrial cells exhibited heterogeneous staining patterns for ER and PR, and this correlated well with endometrial hyperplasia, differentiation and stromal-decidual transformation (Ghosh et al., 1999) .
Insulin-like growth factor I (IGF-I) and IGF-II are potent mitogenic and differentiation-promoting growth factors (Clemens, 1991) . There is robust evidence to support the importance of IGF in the regulation of fetal growth and development in mice Liu et al., 1993) . IGF are involved in the growth and differentiation of trophoblast cells both in vitro (Fant et al., 1986; Ritvos et al., 1988) and in vivo (Guidice et al., 1995; Coulter and Han, 1996) . In a study of human placental tissue recovered between 6 and 8 weeks of gestation, IGF-II was shown to be abundantly expressed by invading cytotrophoblast cells . IGF-II has also been shown to stimulate human trophoblast migration in vitro (Irving and Lala, 1995) . However, none of these studies investigated the involvement of IGF peptides at implantation sites during early stages of implantation and placentation in a primate species. The objective of the present study was to immunohistochemically localize IGF-I and IGF-II peptides in trophoblast cells and in maternal endometrial cells during lacunar and early villous stages of placentation in the Rhesus monkey.
Materials and methods
Animals
Proven fertile male and female Rhesus monkeys were housed singly under semi-natural conditions in the Primate Research Facility of the All India Institute of Medical Sciences, and were fed with a regular monkey pellet diet, semi-formulated Indian bread, fresh seasonal fruits and water ad libitum. Females were allowed to cohabit with their male partners during days 8-16 of their menstrual cycles and during this time peripheral blood samples were collected once daily from female monkeys for the determination of oestradiol-17β and progesterone in peripheral circulation by radioimmunoassays in order to detect the day of ovulation (day 0) and for the determination of chorionic gonadotrophin (mCG) levels in peripheral circulation by enzyme-linked immunosorbent assay in order to detect the day of implantation as described previously (Ghosh et al., 1996 (Ghosh et al., , 1997 . Vaginal smears were checked daily for the presence of spermatozoa. The experimental design of the present study was approved by the Ethics Committee on the Use of Non-Human Primates in Biomedical Research of the AIIMS.
Tissue collection, processing and analysis of implantation sites Prediction of pregnancy was made on the basis of elevated profiles of oestradiol-17β and progesterone and detectable mCG in peripheral circulation (Ghosh et al., 1997) . On estimated days 13-16 after fertilization, animals (n ϭ 10) were laparotomized under ketamine (12 mg/kg body weight; Parke Davis & Co., Mumbai, India) anaesthesia and after checking for the presence of functional corpus luteum, in-situ perfusion was performed using sterile phosphate-buffered saline (pH 7.4) followed by freshly prepared 4% formaldehyde in 0.1 mol/l phosphate buffer, pH 7.4. In-situ perfusion was performed for 45-60 min, and the uterus was quickly excised, placed in fresh fixative on ice and transported to the laboratory. In the laboratory, the uterus was carefully excised to expose its luminal side, the primary implant site was located and carefully excised and kept for fixation for 24 h at 4°C and then processed in a routine manner for paraffin embedding (Ghosh et al., 1999) .
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Based on light microscopic examination of 6 µm haematoxylinstained paraffin wax sections of primary implantation sites, the implantation stage for each sample was classified based on earlier descriptions (Hendrickx, 1971; Enders, 1993) . In the present study, lacunar (n ϭ 4) and early villous (n ϭ 6) stages of primary implantation sites were used. Detailed descriptions of these stages of implantation and placentation in the Rhesus monkey have been given in an earlier report (Ghosh et al., 1999) .
Immunohistochemistry and analysis of immunoprecipitation
Paraffin sections (6 µm) were collected on poly-L-lysine pre-coated glass slides, and immunohistochemical localizations of IGF-I and IGF-II were performed using polyclonal antisera raised in goat against recombinant human (rh)IGF-I and rhIGF-II (R & D Systems, Minneapolis, MN, USA) using a method described earlier (Ghosh et al., 1999) . To help in identifying fetal and maternal endometrial cells at the feto-maternal interface of primary implantation sites, parallel sections were used for the immunolocalization of cytokeratin and vimentin using specific monoclonal antibodies (Dako-CK MNF116 and Dako-vimentin V9, respectively) from Dako A/S (Glostrup, Denmark). All other chemicals were purchased from Sigma Chemical Company (St Louis, MO, USA). Sections were incubated with primary antibody overnight at 4°C, followed by incubation with biotinylated secondary antibody. Final visualization was achieved using the ABC peroxidase kit (Vector Laboratories, Burlingame, CA, USA) and freshly prepared 3,3Ј-diaminobenzidine tetrahydrochloride and hydrogen peroxide according to the protocol provided by the manufacturer. Sections were then counterstained lightly with haematoxylin.
Dilutions of stock primary antibodies for incubation were precalibrated based on 3-5 point titration and the information provided by the manufacturer. Specificity of antibody ligand binding and visualization were assessed by: (i) omitting primary antibodies, (ii) replacing primary antibodies with unrelated immunoglobulin from the same species and other species, and (iii) omitting secondary antibodies and replacing labelled secondary antibody with unrelated labelled immunoglobulin from the same and other species. Specificities of the antibodies against IGF-I and IGF-II were further examined using immunobloting and immunoneutralization on adjacent tissue sections. For a given antibody and dilution, all sections were subjected to immunohistochemistry simultaneously. Late proliferative and mid luteal phase human endometrial tissue sections were used as positive controls.
For the assessment of immunostaining in cells of fetal and endometrial compartments, semiquantitative subjective scoring was done by all three investigators separately using a standardized 5-scale system: 0 (Ͻ5%), 1 (5-25%), 2 (26-50%), 3 (51-75%), 4 (76% and more), as described previously (Press et al., 1988; Ghosh et al., 1999) . The immunostained sections which yielded coefficient of variance more than 10% in the pooled data analysis were not included. It was assumed that these measurements reflected the concentrations of the investigated proteins in fetal and maternal cells at blastocyst implantation sites.
Results Figure 1A -F shows representative lacunar and early villous stages of implantation and placentation of the Rhesus monkey. Light microscopic examination of primary implantation sites revealed the presence of lacunae lined with syncytial trophoblast cells and overlying the chorionic plate on day 13 of gestation. Between days 14 and 16 of gestation, expansion of a Based on semiquantitative subjective scoring using a standardized 5-scale system: 0 (Ͻ5%), 1 (5-25%), 2 (26-50%), 3 (51-75%), 4 (ജ76%). CTB ϭ cytotrophoblast; STB ϭ syncytiotrophoblast.
atin. Endometrial glandular epithelium and plaque acinar epithelium were also cytokeratin-positive. Vimentin-positive maternal endometrial stromal cells were observed surrounding dilated blood vessels and glands at implantation sites. Extraembryonic mesenchymal cells were also vimentin positive ( Figures 1D-F) , and they were also occasionally stained positive for cytokeratin. trophoblast cells associated with lacunae and in adjoining maternal interstitium (Figure 2A ; Table I ), while IGF-II immunostaining was predominant in lamellar syncytiotrophoblast cells lining the syncytial cleft and lacunae ( Figure 2B ; Table I ). Trophoblast cells within the chorionic plate exhibited a lower level of immunostaining, while cells beneath and adjacent to lacunae remained largely negative for IGF-II ( Figure 2B ). The villous trophoblast cells showed very low to no immunostaining for IGF-I (Table I) , while discrete IGF-II peptide was seen in villous syncytiotrophoblast cells (Figure 3) . Although there was only occasional staining for IGF-I and IGF-II in non-polarized trophoblast cells of the cell columns, marked immunostaining for IGF-II was observed in syncytiotrophoblasts lining the cell column, in migrating extravillous trophoblast cells (Figure 4 ) and in endovascular trophoblast cells ( Figure 5 ). Figure 6 shows the absence of immunopositive staining in fetal and maternal endometrial cells in the absence 1 and 4) , recombinant human (rh)IGF-I (100 ng/lane; lanes 2 and 5), and rhIGF-II (100 ng/lane; lanes 3 and 6) were subjected to 15% sodium dodecyl sulphatepolyacrylamide gel electrophoresis and transferred to nitrocellulose membranes and immunodetected using antibodies (1.0 µg/ml) against IGF-I (A) and IGF-II (B). Arrows show immunopositive bands at mol. wt 7.5 kDa. Immunohistochemical neutralization (C-F) was performed with adjacent sections incubated with primary antibodies (5 µg/ml) against IGF-I (C, D) and IGF-II (E, F) in presence of rhIGF-II (C, F) and rhIGF-I (D, E). Bars ϭ 40 µm.
of primary antibodies. In the maternal compartment, a low to moderate level of immunostaining for both IGF-I and IGF-II was seen in plaque epithelial cells, glandular epithelial cells, vascular smooth muscle cells and myometrium in lacunar and villous stages of implantation (Table I ; Figure 7A-D) . Finally, it is not possible to directly compare the relative abundance of two antigens, namely IGF-I and IGF-II, in different subsets of trophoblast cells and maternal endometrial cells at the primary implantation site based on semiquantitative immunohistochemical scoring. It is however noteworthy that the antibodies (1.0 µg/ml) used in the present study were of high sensitivity, with the detection limit being 2.5 ng/lane for IGF-I and 1.0 ng/lane for IGF-II, respectively. As shown in Figure 8 , these antibodies did not show any mutual cross-reactivity.
Discussion
The observed light microscopic changes during lacuna and early villous stages of implantation and placentation at primary implantation stages in the Rhesus monkey were very similar to those reported earlier in the same species (Wislocki and Streeter, 1938; Heuser and Streeter, 1941; Enders et al., 1985; Enders and Schlafke, 1986; Enders, 1993) . All cytotrophoblast and syncytiotrophoblast cell populations were cytokeratin-positive, though no effort was made to differentiate different subsets of trophoblast cells based on their patterns of cytokeratin expression as has been reported earlier for human trophoblast cell populations (Muhlhauser et al., 1995; Vicovac and Aplin, 1996) .
It is generally known that IGF-I and IGF-II are potent mitogenic and differentiation-promoting growth factors and appear to act via paracrine and autocrine as well as classical endocrine mechanisms (Rotwein, 1991) . We now report for the first time that IGF-I and IGF-II peptides are localized, in a cell-type-specific manner, during the very early stages of implantation and placentation in the Rhesus monkey. A low level of IGF-I was immunolocalized in trophoblast cells lining lacunae and primary and secondary villi, while moderate to high amounts of IGF-II were detected in lamellar syncytiotrophoblast cells lining lacunae, villi and cell columns, as well as in migrating trophoblast cells in the extravillous compartment, and in endovascular trophoblast cells. Similar observations have been made in monkey placenta collected during day 65 to term (Coulter and Han, 1996) and in human placental tissue . Maternal endometrial cells, however, showed highly comparable distribution profiles for both IGF-I and IGF-II.
The observed presence of IGF-II peptide in differentiated lamellar syncytiotrophoblast cells during the very early stages of implantation and placentation in the Rhesus monkey may be important in their transition to this differentiated cell population, since it is known that IGF-II functions as an essential survival factor during transition from the proliferating state to the differentiating state (Stewart and Rotwein, 1996) . It is possible that IGF-II regulates the role of syncytiotrophoblast cells in the placental functions of nutrient and oxygen transport as well as placental hormone synthesis and secretion (Roberts and Anthony, 1994; Coulter and Han, 1996) . It has also been suggested that IGF-II produced by trophoblast cells within the chorionic plate, as has been observed in the present study, may potentiate their migratory invasion (Irving and Lala, 1995) and stimulate insulin-like growth factor 1 (IGFBP-1) production by decidual cells in a paracrine manner (Irwin et al., 1993) . IGFBP-1 can in turn influence integrinmediated (Jones et al., 1993; Yelian et al., 1993) migration of cytotrophoblast cells into maternal stroma (Damsky et al., 1993; Irving and Lala, 1995; Bischof et al., 1998; Hamilton et al., 1998; Irwin and Giudice, 1998) .
In the present study, very low amounts of IGF-I peptide were detected in various subsets of trophoblast cells at 370 implantation sites. We have earlier reported that at lacunar and early villous stages of implantation and placentation, trophoblast cells of the Rhesus monkey did not express any appreciable immunostaining for the oestrogen receptor, while they were positive for the progesterone receptor (Ghosh et al., 1999) . Oestrogen stimulates IGF-I gene expression and IGF-I is assumed to mediate oestrogen action in target tissues (Ghosh et al., 1991; Guidice, 1994; Murphy and Ballejo, 1994) . It is likely that undetectable to low levels of ER and IGF-I in trophoblast cells in lacunar and villous stages of development in the Rhesus monkey may be functionally related to the control of trophoblast cell proliferation (Rutanen, 1998) .
IGF-I and IGF-II peptides are abundantly present in uteri of cycling and pregnant rodents, domestic species and humans (Murphy et al., 1987; Tavakkol et al., 1988; Letcher et al., 1989; Carlsson and Billig, 1991; Guidice, 1994; Murphy and Ballejo, 1994; Gao et al., 1995) . We report similar results in the Rhesus monkey during early implantation. Interestingly, endometrial plaque epithelial cells are also immunopositive for both IGF-I and IGF-II. IGF-II expression in human endometrial cells is generally high under progestin dominance (Zhou et al., 1994; Gao et al., 1995) . Thus, the observed moderate level of IGF-II in maternal endometrium during early stages of placentation may arise from the high progesterone concentration in the maternal circulation at that time (Ghosh et al., 1997) . However, a similar trend in the distribution of IGF-I peptide in maternal endometrium was also observed. The level of oestrogen receptor has been shown to be correlated with IGF-I production (Guidice, 1994; Murphy and Ballejo, 1994) , however, the expression of oestrogen receptors occurs at a very low level in endometrial cells at the site of implantation (Salmi et al., 1996; Wang et al., 1996; Ghosh et al., 1999) . On the other hand, a high level of IGF-I was observed in vascular smooth muscle and in myometrium, while these cells showed a moderate degree of IGF-II peptide. It has been observed earlier that myometrial expression of IGF-I is upregulated by steroid hormones, while IGF-II expression appears to be constitutive in myometrial smooth muscle cells in primates (Adesanya et al., 1996) . From the present results, it is likely that some other regulatory factors besides steroid hormones may be involved in the expression of IGF peptides in endometrial and myometrial cells during implantation.
In conclusion, it appears that there is differential distribution of IGF peptides in syncytiotrophoblast, cytotrophoblast and migrating trophoblast cell populations in lacunar and villous stages of gestation in the Rhesus monkey. In order to appreciate the involvement of IGF in the complex process of trophoblast invasion and decidualization in the primate uterus it appears important to examine the IGF-IGFBP-1 involvement at fetomaternal interface in the primate.
